Abbott Launches FDA-Approved Blood Test for Colorectal Cancer Screening
Abbott launches SimpleScreen CRC in the US, adding an FDA-approved blood-based colorectal cancer screening option to its diagnostics portfolio.
American Cancer Society | 03/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy